Eric Eugene Esser - Jun 22, 2023 Form 4 Insider Report for Telesis Bio Inc. (TBIO)

Role
President & COO
Signature
/s/ Rob Cutler, as Attorney-in-Fact
Stock symbol
TBIO
Transactions as of
Jun 22, 2023
Transactions value $
-$1,764
Form type
4
Date filed
3/5/2024, 06:40 PM
Previous filing
Aug 8, 2022
Next filing
Apr 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBIO Common Stock Award $0 +32.6K $0.00 32.6K Jun 22, 2023 Direct F1
transaction TBIO Common Stock Tax liability -$1.76K -3.34K -10.25% $0.53 29.3K Mar 1, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TBIO Stock Option (right to buy) Award $0 +264K $0.00 264K Jun 22, 2023 Common Stock 264K $1.66 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through each applicable vesting date, 25% of the RSUs shall vest on each of March 1, 2024, March 1, 2025, March 1, 2026, and March 1, 2027.
F2 Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs.
F3 Subject to the Reporting Person's continuing as a Service Provider (as defined in the Plan) through each applicable vesting date, twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter.